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That most protein molecules do not last as long as the 
cell in which they reside was suggested more than 60 
years ago, by studies that utilized stable isotopes to 
label proteins in vivo (Schoenheimer, 1942). Despite this 
evidence, the prevailing view, until the 1980s, was that 
intracellular protein degradation was a simple and even 
mundane process, serving largely to dispose of "aged" 
or otherwise damaged proteins. Cellular regulation was 
believed to be a separate affair, mediated primarily by 
repressors and activators of gene expression, which 
were assumed, often tacitly, to be long-lived. Among 
the reasons for this lopsided perspective was the diffi- 
culty of connecting the long-recognized proteolytic sys- 
tem in the lysosomes to specific pathways of intra- 
cellular regulation. Thus, most people studying gene 
expression in the 1960s and 1970s assumed that the 
regulatory circuits they cared about did not involve 
short-lived proteins. As we know now, just the opposite 
proved true, especially in eukaryotes, where many tran- 
scriptional regulators are conditionally short-lived pro- 
teins whose levels in a cell are determined by the rates 
of their ubiquitin-dependent proteolysis at least as much 
as by the rates of their synthesis. Although the con- 
stricting premodern view of the functions of intracellular 
proteolysis wasn't shared by everyone (see, for exam- 
ple, Schimke and Doyle, 1971; Poole et al., 1978), defini- 
tive evidence for the importance of extralysosomal pro- 
tein degradation had to wait until the ts85 studies (Finley 
et al., 1984; Ciechanover et al., 1984). 
Ubiquitin, a 76 residue protein, was identified by G. 
Goldstein and colleagues (Goldstein et al., 1975), who 
detected this protein, of unknown function, in many dif- 
ferent organisms, and gave it a name that in hindsight 
is remarkably apt. The first covalent ubiquitin conjugate, 
to histone H2A, was described in 1977 (Goldknopf and 
Busch, 1977). In 1978, A. Hershko and his graduate stu- 
dents A. Ciechanover and Y. Hod reported that a small 
heat-stable protein was required for the degradation of 
denatured globin added to rabbit reticulocyte xtracts 
(Ciechanover et al., 1978). In 1980, Hershko, Ciechan- 
over and colleagues, in a collaboration with I. Rose, 
demonstrated that the above heat-stable protein, 
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termed APF-1 (ATP-dependent proteolytic factor 1), 
was conjugated to proteins in an ATP-dependent reac- 
tion, and proposed that this event marked conjugated 
proteins for selective degradation (Hershko et al., 1980; 
Ciechanover et al., 1980). Also during this period, it was 
realized, through the work by K. Wilkinson, M. Urban, 
and A. Haas (Wilkinson et al., 1980), that APF-1 and 
ubiquitin were in fact the same protein. 
In 1980-1983, Hershko, Ciechanover, and their col- 
leagues in the Hershko laboratory dissected the enzy- 
matic cascade of ubiquitin conjugation. The initial step 
was shown to involve ubiquitin-activating enzyme, 
termed El, which catalyzed an ATP-dependent reaction 
in which the C-terminal Gly residue of ubiquitin was 
covalently linked, via a thioester bond, to a specific Cys 
residue of El. The activated, El-linked ubiquitin moiety 
was transesterified to specific Cys residues of the ubi- 
quitin-conjugating enzymes (E2s), which thereafter me- 
diated the conjugation of ubiquitin to ~-amino groups 
of Lys residues in substrates of the ubiquitin system 
(Hershko et al., 1983). That E2 existed as a family of 
related but distinct enzymes was demonstrated by Pick- 
art and Rose (1985). Yet another set of proteins, termed 
E3s, was also required for the conjugation reaction, ap- 
parently playing a role in substrate recognition (Hershko 
et al., 1983). Another study (Hershko et al., 1984) showed 
that proteins conjugated to ubiquitin were targeted for 
degradation by a large ATP-dependent protease that 
became known later, through the work of several abora- 
tories, as the 26S proteasome (Hough et al., 1986; re- 
viewed by Zwickl et al., 2000). For a historical account 
of the early biochemical work, see Hershko et al. (2000). 
These essential studies defined the enzymology of ubi- 
quitin conjugation, but did not address the nature of its 
specificity and particularly its physiological functions. 
Consequently, there was, at the time, widespread skep- 
ticism concerning the physiological significance of this 
strange new protein modification. At the beginning of 
1982, Ciechanover, having completed his graduate 
studies with Hershko, arrived to MIT for his postdoctoral 
work in the laboratory of H. Lodish. 
A. Varshavsky, another protagonist of ts85 studies, 
emigrated from Russia to the U.S. in 1977. He joined 
the faculty of MIT's Biology Department, and resumed 
work on the structure of chromosomes, the subject of his 
earlier research in Moscow. In 1978, Varshavsky came 
across the above-mentioned 1977 paper by the Busch 
laboratory (Goldknopf and Busch, 1977) that described 
the ubiquitin-H2A conjugate (Ub-H2A), and decided to 
determine the distribution of this conjugate amongst he 
chromatin's nucleosomes. Back in Russia, he had begun 
to develop a method for high-resolution analysis of 
nucleosomes. These DNA-protein complexes were sub- 
jected to electrophoresis in a low-ionic-strength poly- 
acrylamide gel (a forerunner of the gel shift assay), fol- 
lowed by second-dimension electrophoresis of either 
DNA or proteins. Varshavsky and his postdoctoral stu- 
dent L. Levinger located Ub-H2A in a subset of the 
nucleosomes, succeeded in separating these nucleo- 
somes from those lacking Ub-H2A, and showed that 
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nucleosomes containing Ub-H2A were enriched in tran- 
scribed genes and excluded from the centromeric het- 
erochromatin (Levinger and Varshavsky, 1980, 1982). 
In 1980, Varshavsky saw the paper by Wilkinson et 
al. (1980) about the identity of ubiquitin and APF-1. Two 
seemingly independent realms, protein degradation and 
chromosomes, came together for him, suggesting a reg- 
ulatory pathway of immense complexity and broad, still 
to be discovered, range of functions. Varshavsky de- 
cided to find genetic approaches to the entire problem, 
because a system of such complexity was unlikely to 
be understood through biochemistry alone. In 1980, re- 
verse genetic techniques were about to become feasible 
with the yeast Saccharomyces cerevisiae, but were still 
a decade away from mammalian genetics. Near the end 
of 1980, Varshavsky came across a paper by M. Yamada 
and colleagues that described a conditionally lethal, 
temperature-sensitive mouse cell line called ts85. The 
researchers showed that a specific nuclear protein dis- 
appeared from ts85 cells at increased temperatures, 
and suggested that this protein might be Ub-H2A (Maru- 
nouchi et al., 1980). From the paper's data, Varshavsky 
concluded that the protein in question was virtually cer- 
tain to be Ub-H2A, because in the preceding two years 
his laboratory had learned much about the properties 
of this ubiquitin conjugate. On the hunch that mouse 
ts85 cells might be mutated in a component of the ubi- 
quitin system, Varshavsky wrote to Yamada, and re- 
ceived from him, in 1981, both ts85 and the parental 
("wild-type") cell line called FM3A. 
D. Finley, the third protagonist of ts85 studies, and 
the one who spearheaded this project, joined the Var- 
shavsky laboratory as a graduate student, and soon 
began a systematic study of ts85. A few months into 
the project, Finley and Varshavsky made the crucial ob- 
servation that ubiquitin conjugation in an extract from 
ts85 cells was temperature-sensitive, in contrast to an 
extract from parental cells (Figure 3 in Finley et al., 1984). 
Soon afterward, Varshavsky invited Ciechanover, who 
had been working on unrelated projects in the Lodish 
laboratory, to join him and Finley in the ongoing study 
of ts85 cells. Ciechanover did, the work continued, and 
they eventually submitted two papers (Finley et al., 1984; 
Ciechanover et al., 1984) that described, primarily, the 
following discoveries: 
• mouse ts85 cells have a temperature-sensitive ubiqui- 
tin-activating (El) enzyme. 
• these cells, in contrast o their wild-type counterpart, 
stop degrading the bulk of their short-lived proteins 
at nonpermissive temperature. 
This was the first evidence that ubiquitin conjugation 
was required for protein degradation in vivo. The results 
with ts85 cells also indicated that ubiquitin conjugation 
was essential for cell viability (Finley et al., 1984). In 
addition, ts85 cells were preferentially arrested at the 
G2 phase of the cell cycle, and the synthesis of heat- 
stress proteins was strongly induced in these cells at 
nonpermissive temperature, indicating that ubiquitin 
conjugation was involved in the cell cycle progression 
and stress response (Finley et al., 1984, 1988). In 1983, 
T. Hunt and colleagues discovered unusual proteins in 
clam embryos (Evans et al., 1983). These proteins, which 
they called cyclins, were degraded during exit from mito- 
sis. We suggested that cyclins were destroyed by the 
ubiquitin system (Ciechanover et al., 1984), a hypothesis 
shown to be correct in 1991, by M. Glotzer, A. Murray, 
and M. Kirschner (Glotzer et al., 1991), and indepen- 
dently by Hershko and colleagues (Hershko et al., 1991). 
In one of our two papers, a specific (and at the time 
entirely original) hypothesis was suggested about the 
mechanism of action of heat-stress proteins. It was pro- 
posed that 
the ubiquitin-dependent proteolytic pathway and 
the heat shock response are complementary sys- 
tems designed (among other things) to prevent 
cellular damage that abnormal proteins could in- 
flict .... It is possible that at least some of the heat 
shock proteins recognize the same binding sites 
by which abnormal proteins recognize each other 
in precipitate formation, but bind monovalently to 
abnormal proteins so as to prevent precipitate 
formation (Finley et al., 1984). 
At the time of this hypothesis, which proved correct, 
published speculations on the mechanism of heat- 
stress proteins centered primarily on RNA and chroma- 
tin regulation (Marx, 1983); the era of modern under- 
standing commenced soon after the ts85 work (see, 
for example, Munro and Pelham, 1985). Our other 1984 
proposal was that specific heat-stress proteins such 
as HSP70 and the ubiquitin-dependent proteolysis play 
complementary roles in containing and reversing stress 
damage through the recognition of unfolded proteins 
via exposed hydrophobic surfaces (Finley et al., 1984). 
This has also proven correct, as illustrated by numerous 
papers, and with particular clarity by the recent finding 
that overexpression of ubiquitin can rescue stress resis- 
tance of cells with an impaired expression of heat-stress 
proteins (Friant et al., 2003). Analogous demonstrations 
of the functional coupling between chaperones and pro- 
teolysis have been made in prokaryotic systems (Burton 
et al., 2001, and references therein). 
In addition to having been a breakthrough that indi- 
cated the importance, indeed the requirement, of the 
ubiquitin system for intracellular proteolysis, cell viabil- 
ity, and cell cycle progression, the two ts85 papers were 
also the first instance of a study that addressed the in 
vivo workings of this system. The ts85 papers were thus 
a watershed in more ways than one. They underlay the 
subsequent expansion of the ubiquitin field as well as 
the later scientific strategy by the Varshavsky laboratory. 
Although the ts85 discoveries left little doubt, among 
the optimists, about the importance of the ubiquitin sys- 
tem in cellular physiology, it was difficult o extend these 
findings in the same system, owing to limitations of 
the mammalian somatic cell genetics, which was still 
hampered at that time by the impossibility of altering 
genes at will. In addition, the advances with ts85 cells 
did not address the existence and nature of degradation 
signals, that is, features of proteins that make them 
targets for ubiquitin conjugation. 
Therefore, in 1983, even before the completion of ts85 
work, Finley and Varshavsky, together with other col- 
leagues in the Varshavsky lab, began systematic analy- 
sis of the ubiquitin system in the genetically tractable 
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S. cerevisiae, a project that soon expanded to occupy 
the entire laboratory. Between 1983 and 1990, this work, 
a direct descendant of the ts85 approach, established 
the physiological fundamentals of the ubiquitin field. 
Mentioned below are the key advances of those early 
years. In 1984, Finley, E. Ozkaynak, and Varshavsky 
cloned the first ubiquitin gene, and found it to encode 
a polyubiquitin precursor protein (Ozkaynak et al., 1984). 
By 1987, they showed that this gene, UBI4, was strongly 
induced by different stresses, and that a deletion of 
UBI4 resulted in stress-hypersensitive cells (Finley et 
al., 1987), These results validated some of the above 
described ideas that grew out of the ts85 experiments 
(Finley et al., 1984), thereby establishing one broad and 
essential function of the ubiquitin system. In 1986, A. 
Bachmair, Finley, and Varshavsky discovered, through 
the development of the ubiquitin fusion technique, the 
first degradation signals (degrons) that target proteins 
for ubiquitin conjugation and proteolysis (Bachmair et 
al., 1986). One set of these degradation signals gives 
rise to the N-end rule, which relates the in vivo half- 
life of a protein to the identity of its N-terminal residue 
(Bachmair et al., 1986). The discovery and dissection of 
this pathway (Bachmair et al., 1986; Ferber and Ciechan- 
over, 1987; Reiss et al., 1988; Bachmair and Varshavsky, 
1989) revealed that most of the test substrates in the 
earlier studies (Hershko et al., 1983) were, in fact, N-end 
rule substrates. 
In 1987, S. Jentsch, J. McGrath, and Varshavsky dis- 
covered that RAD6, a protein known to yeast geneticists 
as an essential component of DNA repair pathways, 
was a ubiquitin-conjugating (E2) enzyme, the first such 
enzyme to mediate a specific physiological function 
(Jentsch et al., 1987). A subsequent collaboration be- 
tween B. Byers' and Varshavsky's laboratories demon- 
strated that CDC34, an essential cell cycle regulator, 
was also a ubiquitin-conjugating enzyme (Goebl et al., 
1988). This result extended the ubiquitin-cell cycle con- 
nection of our ts85 work to the first demonstration of a 
specific function of ubiquitin conjugation in cell cycle 
control. 
Soon thereafter, Finley, B. Bartel, and Varshavsky dis- 
covered the functions of the other yeast ubiquitin genes, 
UBI1-UBI3, which were shown to encode fusions of ubi- 
quitin to one protein of the large ribosomal subunit and 
one protein of the small ribosomal subunit (Finley et al., 
1989). The presence of ubiquitin in front of a ribosomal 
protein moiety was found to be extremely transient, yet 
essential for the efficient biogenesis of ribosomes. Ubi- 
quitin acts, in these settings, not as a degradation signal 
but as a cotranslational chaperone (Finley et al., 1989). 
(Redman and Rechsteiner [1989] independently identi- 
fied the orthologous ubiquitin fusions in mammals.) The 
first nonproteolytic function of ubiquitin, mediated by 
its fusions to ribosomal proteins (Finley et al., 1989), 
appeared to be an exceptional case until years later, 
when L. Hicke and H. Riezman discovered that ubiqui- 
tylation of a plasma membrane-embedded receptor sig- 
nals its endocytosis (Hicke and Riezman, 1996). Ubiqui- 
tin is now recognized to have numerous nonproteolytic 
functions. 
In 1989, V. Chau and colleagues in the Varshavsky 
laboratory demonstrated the existence and unique to- 
pology of polyubiquitin chains (Chau et al., 1989), sug- 
gested in an earlier study by Hershko and Heller (1985). 
Chau et al. (1989) also showed that a substrate-linked 
polyubiquitin chain was essential for the substrate's 
degradation by the proteasome, another beginning of 
what, nowadays, is a major area of ubiquitin studies. In 
1990, E, Johnson, D. Gonda, and Varshavsky discovered 
that ubiquitin-dependent proteolysis of oligomeric pro- 
teins is subunit-selective, a fundamental feature of the 
ubiquitin system that allows protein degradation to be 
wielded as an instrument of either negative or positive 
control (Johnson et al., 1990). Among many examples 
are activation of the transcription factor NF-KB, through 
selective degradation of the inhibitory subunit IKB, and 
inactivation of the cyclin-dependent kinases, through 
selective degradation of their cyclin subunits. 
By the early 1990s, several physiological substrates 
of the ubiquitin system were identified, including MAT~2 
(Hochstrasser and Varshavsky, 1990; Hochstrasser et 
al., 1991), p53, Myc, Fos (Scheffner et al., 1990; Ciechan- 
over et al., 1991), and cyclins (Glotzer et al., 1991; 
Hershko et al., 1991). More and more laboratories began 
to study the ubiquitin system. The trickle became a 
flood, and today research on ubiquitin is going from 
strength to strength in hundreds of laboratories through- 
out the world. Within a decade from now, we will proba- 
bly see useful drugs that target specific components of 
the ubiquitin system, and also, with luck, drugs that will 
direct this system to destroy (and thereby to functionally 
inactivate) any specific protein. Ubiquitin studies are 
now one of the largest and most important arenas of 
modern biology, the point of convergence of many dis- 
parate disciplines. The ts85 work (Finley et al., 1984; 
Ciechanover et al., 1984) played a key role in bringing 
about this major change in outlook, in that it established 
the ubiquitin system as the dominant pathway for selec- 
tive protein degradation and at the same time revealed 
the broad significance of this process. 
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Summary 
Ubiquitin, a 76 residue protein, occurs in eucaryotic 
cells either free or covalently joined to a variety of 
protein species. Previous work suggested that ubi- 
quitin may function as a signal for attack by protein- 
ases specific for ubiquitin-protein conjugates. We 
show that the mouse cell line ts85, a previously 
isolated cell cycle mutant, is temperature-sensitive 
in ubiquitin-protein conjugation, and that this effect 
is due to the specific thermolability of the ts85 ubi- 
quitin-activating enzyme (El). From E1 thermoinac- 
tivation kinetics in mixed (wild-type plus ts85) ex- 
tracts, and from copurification of the determinant of 
E1 thermolability with E1 in ubiquitin-affinity chro- 
matography, we conclude that the determinant of E1 
thermolabiiity is contained within the E1 polypeptide. 
ts85 cells fail to degrade otherwise short-lived intra- 
cellular proteins at the nonpermissive temperature 
(accompanying paper), demonstrating that degra- 
dation of the bulk of short-lived proteins in this 
higher eucaryotic cell proceeds through a ubiquitin- 
dependent pathway. We discuss possible roles of 
ubiquitin-dependent pathways in DNA transactions, 
the cell cycle, and the heat shock response. 
Introduction 
Ubiquitin is a 76 residue protein abundant in apparently all 
eucaryotic cells. Its amino acid sequence is one of the 
most conserved known, being identical in humans and 
insects (Goldstein et al., 1975; Gavilanes et al., 1982). 
Ubiquitin occurs in cells either free or covalently coupled 
via its carboxyl terminus to e-amino groups of lysine resi- 
dues in a wide variety of intracellular protein species, the 
most abundant of which is apparently histone H2A (Chin 
et al., 1982; Atidia and Kulka, 1982). The ubiquitin-H2A 
semihistone (uH2A), in which the carboxyl terminus of 
ubiquitin is joined via an isopeptide bond to the internal 
lysine 119 in histone H2A (Goldknopf et al., 1975; Busch 
and Goidknopf, 1981; see also West and Bonner, 1980), 
substitutes for one or both of the nucleosomal H2A mole- 
cules in 10% to 20% of nucleosomes; ubiquitinated nu- 
cleosome species occur preferentially within transcribed 
chromosomal regions (Levinger and Varshavsky, 1980, 
1982; Varshavsky et al., 1983). A specific factor required 
for ATP-dependent, nonlysosomal proteolysis in reticulo- 
cyte extracts (Ciechanover et al., 1978) was purified and 
shown to form multiple covalent conjugates to acceptor 
proteins in the presence of reticulocyte xtracts (Ciechan- 
over et al., 1980; Hershko et al., 1980). This factor was 
subsequently identified as ubiquitin (Wilkinson et al., 1980). 
The proposed mechanism of ubiquitin action in this system 
(see Figure 1) is through isopeptide bond formation to 
substrates for proteolysis; one possible role of ubiquitin is 
to serve as a signal for attack by proteinases specific for 
ubiquitin-protein conjugates (Hershko and Ciechanover, 
1982). 
The enzymatic pathway of ubiquitin conjugation in retic- 
ulocyte extracts has recently been elucidated (Hershko et 
al., 1983). The four steps of isopeptide bond formation 
(and the participating enzymes of the ubiquitin-protein 
ligase system) are ubiquitin carboxy-terminal denyiation 
(enzyme El), thiolester bond formation (El), transesterifi- 
cation (El and E2), and ubiquitin-protein conjugate for- 
mation (E2 and E3) (Figure 1; see also Hershko and 
Ciechanover, 1982; Haas and Rose, 1982; Ciechanover et 
al., 1984a). At least some of the isopeptide bonds between 
ubiquitin and acceptor proteins can be reversed, with 
regeneration of both moieties, by the action of an isopep- 
tidase, a distinct and abundant enzyme (Andersen et al., 
1981; Matsui et al., 1982; see also Rose and Warms, 
1983). 
Independent experimental approaches have suggested 
that ubiquitin-mediated, nonlysosomal proteolysis occurs 
not only in terminally differentiating, anucleate reticulocytes 
but also in a variety of other mammalian cell types (Hershko 
et al., 1982; Chin et al., 1982). However, ubiquitin-depend- 
ent proteolysis in extracts from nucleated eucaryotic cells 
has not been reported. Achieving a detailed understanding 
of the design and functional significance of the ubiquitin 
system would require some means to perturb the ubiquitin 
system specifically in vivo. 
Here we demonstrate the thermolability of ubiquitin- 
activating enzyme (El) purified from ts85 cells. A cell cycle 
mutant, ts85 is a temperature-sensitive d rivative of FM3A, 
a cell line established from a spontaneous mouse mam- 
mary carcinoma (Mita et al., 1980), ts85 has a complex 
but well defined phenotype: shift-up of ts85 cultures to a 
nonpermissive temperature rapidly and completely inhibits 
the generation of new mitotic cells (Mita et al., 1980; 
Matsumoto et al., 1980), and the initially unsynchronized 
ts85 cultures evolve a stable distribution of cell cycle 
positions composed of early G2 and (fewer) late S phase 
cells (Mita et al., 1980; Yasuda et al., 1981). The rate of 
histone H1 phosphorylation in vivo was measured in syn- 
chronized G2 and G1/S ts85 cultures, and in both in- 
stances ts85 showed a temperature-dependent defect 
(Matsumoto et al., 1908; Yasuda et al., 1981). However, 
both cytoplasmic and nuclear protein kinase activities from 
ts85 cells, tested with histone H1 as a substrate, behaved 
as wild type in thermoinactivation experiments in vitro 
(Yasuda et al., 1981), suggesting that the reduction in H1 
phosphorylation is secondary to some other defect. 
Remarkably, a temperature-sensitive modification of yet 
another histone (H2A) was identified. The ubiquitin-H2A 
semihistone, uH2A, disappeared from the ts85 chromatin 
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Summary 
We have shown that covalent conjugation of ubiqui- 
tin to proteins is temperature-sensitive in the mouse 
cell cycle mutant ts85 due to a specifically thermo- 
labile ubiquitin-activating enzyme (accompanying 
paper). We show here that degradation of short- 
lived proteins is also temperature sensitive in ts85, 
in contrast to wild-type and revertant cells. While 
more than 70% of the prelabeled abnormal proteins 
(containing amino acid analogs) or puromycyl pep- 
tides are degraded within 4 hr at the permissive 
temperature in both ts85 and wild-type cells, less 
than 15% are degraded in ts85 cells at the nonper- 
missive temperature. Degradation of abnormal pro- 
teins and puromycyl peptides in both ts85 cells and 
wild-type cells is nonlysosomal and ATP-dependent. 
Immunochemical analysis shows a strong and spe- 
cific reduction in the levels of in vivo labeled ubiqui- 
tin-protein conjugates at the nonpermissive temper- 
ature in ts85 cells. Degradation of normal, short- 
lived proteins is also specifically temperature sen- 
sitive in ts85. We suggest that the contribution of 
ubiquitin-independent pathways to the degradation 
of short-lived proteins in this higher eucaryotic cell 
is no more than 10%, and possibly less. 
Introduction 
Intracellular protein degradation in eucaryotes is poorly 
understood with regard to both mechanisms and functions. 
Most cellular proteins turn over at a significant rate; more- 
over, certain regulatory proteins are exceptionally short- 
lived. The intracellular levels of such unstable proteins can 
be adjusted with sensitivity and speed through regulated 
changes in their rates of synthesis or degradation. Bio- 
chemical and genetic analyses in E. coil have revealed 
specific regulatory mechanisms that involve, in particular, 
inducible protein degradation (SOS response; reviewed by 
Little and Mount, 1982) and tight regulation of the stability 
of specific regulatory proteins (phage lambda develop- 
ment; Gottesman et al., 1981; Hoyt et al., 1982). 
In eucaryotic cells, proteins are degraded through both 
lysosomal and nonlysosomal pathways. While the degra- 
dation of endocytosed proteins is a constitutive function 
of the lysosome, it is primarily under conditions of nutritional 
deprivation that significant lysosomal degradation of intra- 
cellular proteins is observed (for reviews see Goldberg and 
St. John, 1976; Hershko and Ciechanover, 1982; Ciechan- 
over et al., 1984). Nonlysosomal, ATP-dependent mecha- 
nisms are probably responsible for most of the highly 
selective turnover of intracellular proteins under normal 
metabolic conditions. A system with these characteristics 
has been solubilized from rabbit reticulocytes (Etlinger and 
Goldberg, 1977) and characterized in detail (Hershko and 
Ciechanover, 1982; Ciechanover et al., 1984). The system 
consists of several essential components, most notably 
ubiquitin, a 76 residue protein abundant in apparently all 
eucaryotic cells. Ubiquitin occurs in cells either free or 
covalently coupled via its oarboxyl terminus to ~-amino 
groups of lysine residues in a wide variety of intracellular 
protein species, the most abundant of which in nucleated 
mammalian cells is apparently ubiquitin-H2A semihistone 
(uH2A; see accompanying paper by Finley et al., 1984, for 
references and discussion of the nuclear ubiquitin--histone 
conjugates). 
The enzymatic pathway of ubiquitin conjugation in retic- 
ulocyte extracts has recently been elucidated (Hershko et 
al., 1983). Ubiquitin-protein ligase, a muitienzyme system, 
catalyzes the covalent coupling of ubiquitin to protein 
substrates; more than one ubiquitin molecule can be joined 
to a single protein molecule (for reviews see Hershko and 
Ciechanover, 1982; Ciechanover et al., 1984). Two addi- 
tional components of the in vitro system are an isopepti- 
dase, which cleaves isopeptide bonds between ubiquitin 
and substrate proteins (Andersen et al., 1981; Matsui et 
al., 1982), thus establishing a substrate cycle of ubiquitin- 
ation-deubiquitination, and proteinases (as yet unidenti- 
fied) needed to degrade ubiquitin-protein conjugates to 
peptide fragments, from which isopeptidase could hypo- 
thetically release free ubiquitin for reuse (Hershko et al., 
1980; see also Figure 1 in Finley et al., 1984). 
Successful extraction of a ubiquitin-dependent proteo- 
lyric system from nucleated eucaryotic cells has not been 
reported as yet. In vivo studies have suggested that ubi- 
quitin-dependent nonlysosomal protein degradation oc- 
curs not only in terminally differentiating, anucleate reticu- 
Iocytes but also in a variety of other cell types (Hershko et 
al., 1982; Chin et al., 1982); however, distinctly different 
possibilities are not excluded by the sparse and correlative 
data currently available. 
We have begun to analyze the mouse cell cycle mutant 
ts85 (Mita et al., 1980; Marunouchi et al., 1982), hoping to 
draw more definitive conclusions regarding the ubiquitin 
system, ts85 cells shifted to the nonpermissive tempera- 
ture (39°C) arrest largely at the G2 phase of the cell cycle. 
Since ts85 cells lose most of their uH2A semihistone at 
the nonpermissive temperature (Matsumoto et al., 1983; 
see Finley et al., 1984, for more details of the ts85 phe- 
notype), we tested the possibility that the primary lesion in 
ts85 cells was in the ubiquitin-protein ligase system. In the 
accompanying paper (Finley et al., 1984), we have shown 
that this is indeed the case, and that the thermolabile 
polypeptide is ubiquitin-activating enzyme (El), a compo- 
nent of the ubiquitin-protein ligase system (Hershko et al., 
1983). 
In the present paper we show that the ts85 cells, unlike 
